ARCHIVES

Treatment Division Outlines Future Program Areas

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

History: Breast Cancer Screening A 30-Year War Against “Confusion”

November 20, 2009

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988